Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GNMSF) Cash & Current Investments (2023 - 2025)

Historic Cash & Current Investments for Genmab A (GNMSF) over the last 3 years, with Q4 2025 value amounting to $1.7 billion.

  • Genmab A's Cash & Current Investments fell 2257.34% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 billion, marking a year-over-year decrease of 2257.34%. This contributed to the annual value of $1.7 billion for FY2025, which is 2257.34% down from last year.
  • Latest data reveals that Genmab A reported Cash & Current Investments of $1.7 billion as of Q4 2025, which was down 2257.34% from $1.9 billion recorded in Q3 2025.
  • In the past 5 years, Genmab A's Cash & Current Investments registered a high of $2.4 billion during Q4 2023, and its lowest value of $624.0 million during Q2 2024.
  • For the 3-year period, Genmab A's Cash & Current Investments averaged around $1.7 billion, with its median value being $1.7 billion (2025).
  • The largest annual percentage gain for Genmab A's Cash & Current Investments in the last 5 years was 12724.36% (2025), contrasted with its biggest fall of 2472.31% (2025).
  • Over the past 3 years, Genmab A's Cash & Current Investments (Quarter) stood at $2.4 billion in 2023, then fell by 7.86% to $2.2 billion in 2024, then dropped by 22.57% to $1.7 billion in 2025.
  • Its Cash & Current Investments stands at $1.7 billion for Q4 2025, versus $1.9 billion for Q3 2025 and $1.4 billion for Q2 2025.